Abstract
Haemostasis is systematically organized multiple processes that prevent blood flowing through a damaged vessel. In other words, haemostasis is a physiological state in which the concentration of coagulants in a human body is well balanced with that of anticoagulants. The normal human body has an excellent automatic control system for activating pro/anti-coagulants at an appropriate time. When there is any injury in the vessel, a clotting cascade is immediately activated to prevent leaking of blood from the vessel. Upon injury, vascular endothelium activates the haemostasis process (both activating and inhibiting the clots simultaneously) and platelets start to adhere. With platelet adhesion and contact activation stimulates thrombin, which aggregates platelets. Then fibrinogen becomes fibrin, which eventually forms fibrin meshes.3,9,12,16 These meshes trap blood cells and form blood clots. On the process of wound healing, anti-coagulants become activated to dissolve the clot inside of the vessel and, finally, to let the blood go through the healed and recanalized vessel. When haemostasis fails due to an imbalance in necessary coagulants and anticoagulants, it can lead to disastrous physiological conditions, such as bleeding in major organs, embolism, and even sudden death. Without maintaining haemostasis, human blood cannot be transported to various organs properly. Since oxygen is transported through hemoglobin in red blood cells, haemostasis is one of the most important physiological mechanisms and the crucial process for appropriate oxygen transport in the human body.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Barnett, J.T., Hemelt, M.W., Kang, K.A., and Bruley, D.F., “Near Infrared Time Resolved Spectroscopy for the Detection of Deep Vein Thrombosis within the Human Leg,” ISOTT XXIV, Advances in Experimental Medicine and Biology, Plenum, New York (in press).
Bruley, D.F. and Drohan, W.N., Protein C and Related Anticoagulants — Advances in Applied Biotechnology Series, 11, Gulf Publishing Company, Houston, 1990.
Colman, R.W., Hirsh, J., Marder, V.J., and Salzman, E.W., Hemostasis and Thrombosis: Basic Principles and Clinical Practice, second edition, J.B. Lippincott Company, Philadelphia, 1987.
Dalton, J., Bruley D.F., Kang, K.A., and Drohan, W.N., “Separation of Human Protein C from Transgenic Animal Milk using Metal Affinity Chromatography,” ISOTT XVIII, Advances in Experimental Medicine and Biology, (Nemoto, E.M. and Lamana, J.C., eds.), 411, p. 419–428, Plenum, New York, 1997.
Hemelt, M.W., Barnett, J.T., Bruley, D.F., Kang, K.A., “The application of NIR-TRS and Frequency Response Analysis for Deep Vein Thrombosis Detection,” Biotechnology Progress, 13, p. 640–648, 1997.
Kang, K.A., Ryu, D., Drohan, W.D., and Orthner, C.L., “Effect of Matrices on the Immunoaffinity Purification of Protein C,” Biotech. & Bioengr., 39, p. 1086–1098, 1992.
Kang, K.A., Anis, N.A., Eldefrawi, M.E., Drohan, W.N., and Bruley, D.F., “Reusable, Real-Time, Immuno-Optical Protein C-Biosensor,” ISOTT XVIII, Advances in Experimental Medicine and Biology (Nemoto, E.M. and Lamana, J.C. eds.), 411, p. 437–444, Plenum, New York, 1997.
Marciniak, E., Wilson, D., and Marlar, R., “Neonatal Purpura Fulminans: A Genetic Disorder Related to the Absence of Protein C in Blood,” Blood, 65, p. 15–20, 1985.
Ruggeri, Z.M., Clinics in Haematology: Coagulation Disorders,W.B. Saunders Company, London, 1985.
Shearer, M.J., “Annotation: Vitamin K and Vitamin K-Dependent Proteins,” British Journal of Haematology, 75, p. 156–162, 1990.
Spiker, J.O., Kang, K.A., Drohan, W.N., Bruley, D.F., “Protein C Detection Via Fluorophore Mediated Immuno-Optical Biosensor,” ISOTT XXIV, Advances in Experimental Medicine and Biology, Plenum, New York (in press).
Thomson, J.M., Blood Coagulation and Haemostasis, Churchill Livinston, 3rd ed., New York, 1985.
Velander, W.H., Johnson, J.L., Page, R.L., Russell, C.G., Subramanian, A., Wilkins, T.D., Gwazmauskas, F.C., and Drohan, W.N., “High-level expression of Heterologous Protein in the Milk of Transgeneic Sinen using the cDNA encoding Human Protein C,” Proc. Natl. Acad. Sci, 89, p. 12003–12007, 1992.
Wilkins, T.D. and Velander, W.H., “Isolation of Recombinant Proteins from Milk,” Journal of Cellular Biochemistry, 49, p. 333–338, 1992.
Wu, H., Bruley, D.F., Kang, K.A. and Drohan W.N., “Protein C Separation from Human Plasma Cohn Fraction IV-1 Using Immobilized Metal Affinity Chromatography,” Topical Conference on Separation Science and Technologies—1997 Annual AIChE Conference, p. 1443–1448, 1997.
Zwaal, R.F.A. and Hemker, H.C., Blood Coagulation, Elsevier, New York, 1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kang, K.A. (1998). Pro-/Anti-Coagulants and Oxygen Transport in Tissue. In: Hudetz, A.G., Bruley, D.F. (eds) Oxygen Transport to Tissue XX. Advances in Experimental Medicine and Biology, vol 454. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4863-8_79
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4863-8_79
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7206-6
Online ISBN: 978-1-4615-4863-8
eBook Packages: Springer Book Archive